The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Update analysis: Prospective observational study for the impact of short-term periodic steroid premedication for cancer chemotherapy on bone metabolism—ESPRESSO-01 study.
 
Michio Nakamura
Honoraria - Chugai Pharma; Sanofi; Takeda; Yakult Honsha
Consulting or Advisory Role - Bayer Yakuhin
Travel, Accommodations, Expenses - Lilly Japan; Taiho Pharmaceutical
 
Atsushi Ishiguro
No Relationships to Disclose
 
Tetsuhito Muranaka
No Relationships to Disclose
 
Satoshi Yuki
Speakers' Bureau - Bayer Yakuhin; Bristol-Myers Squibb Japan; Chugai Pharma; Lilly Japan; Merck Serono; Taiho Pharmaceutical; Takeda
 
Taichi Murai
No Relationships to Disclose
 
Chika Matsuda
No Relationships to Disclose
 
Ayane Oba
No Relationships to Disclose
 
Kazufumi Itaya
No Relationships to Disclose
 
Taku Shigesawa
No Relationships to Disclose
 
Yuta Koike
No Relationships to Disclose
 
Yomo Fujita
No Relationships to Disclose
 
Ayana Endo
No Relationships to Disclose
 
Yoko Tsukuda
No Relationships to Disclose
 
Yuji Ono
No Relationships to Disclose
 
Takahiko Kudo
No Relationships to Disclose
 
Atsushi Nagasaka
No Relationships to Disclose
 
Shuji Nishikawa
No Relationships to Disclose
 
Yoshito Komatsu
Speakers' Bureau - Bayer Yakuhin; Bristol-Myers Squibb Japan; Chugai Pharma; Daiichi Sankyo; Lilly Japan; Merck Serono; MSD Oncology; Ono Pharmaceutical; Taiho Pharmaceutical; Takeda